Michael E.  Prevoznik net worth and biography

Michael Prevoznik Biography and Net Worth

Michael E. Prevoznik is Senior Vice President, and General Counsel for Quest Diagnostics.

In addition to ensuring that Quest Diagnostics meets all of its legal requirements as a public company, he is also responsible for, security and government affairs. From April 2011 to January 2017, Mr. Prevoznik also had management responsibility for the company’s diagnostic information services activities outside of the U.S., and from April 2011 to January 2013, he had management responsibility for the company’s clinical trials business. From 1999 until April 2009, Mr. Prevoznik also had responsibility for the Company's Compliance Department He was appointed Vice President and General Counsel in 1999, and was named a Senior Vice President in 2003.

Mr. Prevoznik joined Quest Diagnostics in 1999 through the acquisition of SmithKline Beecham Clinical Laboratories (SBCL). He joined SBCL in 1994 as Chief Legal Compliance Officer, and in 1996 was named Vice President and Chief Legal Compliance Officer for SmithKline Beecham Healthcare Services. In 1998, he was appointed Vice President, Compliance, for SmithKline Beecham, a role in which he developed and led the company’s global compliance activities.

Prior to joining SmithKline Beecham, Mr. Prevoznik represented SBCL as outside legal counsel as an Associate with Dechert Price & Rhoads of Philadelphia, where he specialized in healthcare and general corporate law.

Mr. Prevoznik holds a Bachelor of Science degree from the University of Notre Dame, and an M.B.A. from the University of Chicago. He earned his J.D. degree from the University of Pennsylvania Law School.

What is Michael E. Prevoznik's net worth?

The estimated net worth of Michael E. Prevoznik is at least $5.26 million as of February 29th, 2024. Mr. Prevoznik owns 38,478 shares of Quest Diagnostics stock worth more than $5,261,482 as of April 23rd. This net worth evaluation does not reflect any other investments that Mr. Prevoznik may own. Additionally, Mr. Prevoznik receives a salary of $881,230.00 as SVP at Quest Diagnostics. Learn More about Michael E. Prevoznik's net worth.

How old is Michael E. Prevoznik?

Mr. Prevoznik is currently 62 years old. There are 5 older executives and no younger executives at Quest Diagnostics. Learn More on Michael E. Prevoznik's age.

What is Michael E. Prevoznik's salary?

As the SVP of Quest Diagnostics Incorporated, Mr. Prevoznik earns $881,230.00 per year. There are 3 executives that earn more than Mr. Prevoznik. The highest earning executive at Quest Diagnostics is Mr. James E. Davis, Chairman, CEO & President, who commands a salary of $2,880,000.00 per year. Learn More on Michael E. Prevoznik's salary.

How do I contact Michael E. Prevoznik?

The corporate mailing address for Mr. Prevoznik and other Quest Diagnostics executives is 500 PLAZA DRIVE, SECAUCUS NJ, 07094. Quest Diagnostics can also be reached via phone at (973) 520-2700 and via email at [email protected]. Learn More on Michael E. Prevoznik's contact information.

Has Michael E. Prevoznik been buying or selling shares of Quest Diagnostics?

Michael E. Prevoznik has not been actively trading shares of Quest Diagnostics during the past quarter. Most recently, Michael E. Prevoznik sold 5,611 shares of the business's stock in a transaction on Thursday, February 29th. The shares were sold at an average price of $125.88, for a transaction totalling $706,312.68. Following the completion of the sale, the senior vice president now directly owns 38,478 shares of the company's stock, valued at $4,843,610.64. Learn More on Michael E. Prevoznik's trading history.

Who are Quest Diagnostics' active insiders?

Quest Diagnostics' insider roster includes Michael Deppe (CAO), Catherine Doherty (SVP), Mark Guinan (CFO), Michael Prevoznik (SVP), Timothy Ring (Director), Stephen Rusckowski (CEO), Daniel Stanzione (Director), and Gail Wilensky (Director). Learn More on Quest Diagnostics' active insiders.

Are insiders buying or selling shares of Quest Diagnostics?

In the last twelve months, insiders at the medical research company sold shares 5 times. They sold a total of 15,150 shares worth more than $1,913,201.65. The most recent insider tranaction occured on February, 29th when SVP Michael E Prevoznik sold 5,611 shares worth more than $706,312.68. Insiders at Quest Diagnostics own 0.8% of the company. Learn More about insider trades at Quest Diagnostics.

Information on this page was last updated on 2/29/2024.

Michael E. Prevoznik Insider Trading History at Quest Diagnostics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/29/2024Sell5,611$125.88$706,312.6838,478View SEC Filing Icon  
2/22/2024Sell661$126.14$83,378.5440,206View SEC Filing Icon  
2/24/2023Sell1,415$141.42$200,109.3039,440View SEC Filing Icon  
5/17/2022Sell50,604$139.97$7,083,041.8839,224View SEC Filing Icon  
3/8/2022Sell6,228$135.21$842,087.88View SEC Filing Icon  
5/5/2021Sell44,939$137.00$6,156,643.0085,091View SEC Filing Icon  
3/10/2021Sell5,574$120.47$671,499.78
2/24/2021Sell1,188$116.95$138,936.6042,596View SEC Filing Icon  
10/14/2020Sell35,591$119.00$4,235,329.0075,678View SEC Filing Icon  
3/11/2020Sell2,175$104.25$226,743.7544,436View SEC Filing Icon  
2/27/2020Sell690$109.02$75,223.8041,445View SEC Filing Icon  
11/27/2019Sell44,556$107.43$4,786,651.0851,321View SEC Filing Icon  
2/25/2019Sell336$88.23$29,645.2842,108View SEC Filing Icon  
4/20/2017Sell29,513$100.00$2,951,300.0041,335View SEC Filing Icon  
3/16/2017Sell13,987$100.00$1,398,700.0054,309View SEC Filing Icon  
2/27/2017Sell440$97.39$42,851.6041,734View SEC Filing Icon  
3/3/2015Sell3,261$71.16$232,052.76View SEC Filing Icon  
8/4/2014Sell14,377$61.01$877,140.77View SEC Filing Icon  
7/30/2014Sell16,384$62.51$1,024,163.84View SEC Filing Icon  
6/18/2013Sell126,667$62.64$7,934,420.88View SEC Filing Icon  
See Full Table

Michael E. Prevoznik Buying and Selling Activity at Quest Diagnostics

This chart shows Michael E Prevoznik's buying and selling at Quest Diagnostics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Quest Diagnostics Company Overview

Quest Diagnostics logo
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Read More

Today's Range

Now: $136.74
Low: $133.11
High: $138.91

50 Day Range

MA: $128.50
Low: $123.80
High: $136.74

2 Week Range

Now: $136.74
Low: $119.59
High: $148.62

Volume

2,088,321 shs

Average Volume

1,057,877 shs

Market Capitalization

$15.19 billion

P/E Ratio

18.26

Dividend Yield

2.21%

Beta

0.91